MERS Coronavirus in Dromedary Camel Herd, Saudi Arabia by Peiris, JSM et al.
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	20,	No.	7,	July	2014	 1231
MERS Coronavirus 
in Dromedary 
Camel Herd, 
Saudi Arabia
Maged G. Hemida,1 Daniel K.W. Chu,1  
Leo L.M. Poon, Ranawaka A.P.M. Perera, 
Mohammad A. Alhammadi, Hoi-yee Ng,  
Lewis Y. Siu, Yi Guan, Abdelmohsen Alnaeem, 
and Malik Peiris
A prospective study of a dromedary camel herd during 
the	2013–14	calving	season	showed	Middle	East	 respira-
tory syndrome coronavirus infection of calves and adults. 
Virus	was	 isolated	 from	the	nose	and	 feces	but	more	 fre-
quently	from	the	nose.	Preexisting	neutralizing	antibody	did	
not appear to protect against infection.
Ongoing transmission of Middle East respiratory syn-drome coronavirus (MERS-CoV) to humans under-
scores the need to understand the animal sources of zoonot-
ic infection (1,2). MERS-CoV RNA has been detected in 
dromedary camels (3,4), and dromedary infection precedes 
human infection (5). We conducted a prospective study in 
dromedary herds in Al-Hasa, Saudi Arabia, through the 
peak calving season (December 2013–February 2014) to 
document virologic features of MERS-CoV infection in 
these animals.
The Study
We studied dromedaries at 2 farms in Al-Hasa, 4–5 
km apart. Farm A had 70 animals; 4 were 1 month of 
age, 8 were ≈1 year of age, and the rest were adults (>2 
years of age). The herd did not go to pasture in the des-
ert (“zero-grazing”; type of grazing may influence types 
of potential exposures). The animals were sampled on 5 
occasions during November 2013–February 2014. Farm 
B (“semi–zero-grazing”) had 17 adults and 3 calves; its 
herd was sampled in February 2014. Nasal, oral, or rectal 
swab samples and blood samples were collected (Table 1; 
online Technical Appendix Table, http://wwwnc.cdc.gov/
EID/article/20/7/14-0571-Techapp1.pdf). Swab and serum 
samples were stored frozen at −80°C until testing.
Hydrolysis probe–based real-time reverse transcrip-
tion PCR (RT-PCR) targeting MERS-CoV upstream of 
E (UpE) and open reading frame (ORF) 1a genes and a 
broad-range RT-PCR reacting across the CoV family to 
detect other CoVs were used as described (4). Specimens 
initially positive for MERS-CoV were re-extracted and re-
tested to confirm the positive results.
The full genome of MERS-CoV was obtained directly 
from the clinical specimens with 3–4 times coverage by se-
quencing PCR amplicons with overlapping sequence reads 
and sequence assembly (4). Dromedary MERS-CoV full 
genomes obtained in this study (GenBank accession nos. 
KJ650295–KJ650297) were aligned with human MERS-
CoV genomes retrieved from GenBank. We constructed 
full-genome phylogenies using MEGA5 with neighbor-
joining and bootstrap resampling of 500 replicates (6). 
Virus isolation was attempted in Vero E6 cells. We tested 
serum samples for neutralizing antibody titers using a vali-
dated MERS-CoV spike pseudoparticle neutralization test 
(7) (online Technical Appendix).
At farm A, we detected MERS-CoV in 1 of 4 drom-
edaries sampled on November 30, none of 11 sampled on 
December 4, nine of 11 sampled on December 30, and none 
of 9 sampled on February 14 (Table 1). Of the 10 drom-
edaries that tested positive for MERS-CoV, 9 had parallel 
nasal and fecal specimens tested, with virus detected in the 
nasal swab specimens from 8 and the fecal specimen from 
1. At the December 30 sampling, 7 of 8 calves and 2 of 3 
adults tested positive for MERS-CoV, indicating that when 
MERS-CoV circulates on a farm, both calves and adults 
can be infected (online Technical Appendix Table). Be-
cause all 12 adults with serum collected before December 
30 were seropositive (titers >320), it is likely, though not 
certain, that the MERS-CoV infections in the 2 adults (nos. 
21, 19Dam) sampled on December 30 were reinfections, 
as has been reported for other CoVs (8). The seronegative 
1-year-old calves, nos. 13 and 14, had the highest nasal vi-
ral loads (UpE assay 1.3 × 108 to 1.78 × 108/mL specimen), 
and a 2-week-old calf, no. 22, with (presumably passively 
acquired) titers of 1,280 became infected but had a much 
lower viral load. Overall, these data suggest that prior in-
fection or passively acquired maternal antibody might not 
provide complete protection from infection (online Techni-
cal Appendix Table).
Four MERS-CoV–positive calves had mild respiratory 
signs (cough, sneezing, respiratory discharge), abnormally 
elevated body temperature, and loss of appetite at the De-
cember 30 sampling, which resolved over a few days. Three 
calves from which paired serum samples were available 
(Table 2; nos. 13, 15, 17) demonstrated >4-fold rising anti-
body titers to MERS-CoV. Calf no. 13 (1 year of age) had 
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a high viral load and was seronegative at the first MERS-
CoV–positive result (indicating that it had been recently 
infected) but was MERS-CoV RNA negative 6 weeks 
later, suggesting that virus shedding is not prolonged. We 
did not detect virus RNA by RT-PCR in the 3 acute-phase 
serum samples from infected dromedaries (nos. 1, 16, 17), 
suggesting that acute infection is not associated with pro-
longed viremia. Dromedaries from farm B were sampled 
once on February 11; all results were negative.
The full genomes of MERS-CoV sequenced directly 
from a nasal swab specimen collected on November 30 
were identical to those from a nasal swab specimen and a 
fecal specimen collected on December 30. In addition, the 
complete spike gene was sequenced from 4 other MERS-
CoV–positive nasal swab specimens, and these spike genes 
were genetically identical.
Virus isolation in Vero E6 cells was attempted from 
7 positive nasal swab and fecal specimens that had >106 
copies/mL in the original sample in the UpE RT-PCR. Vi-
ruses were isolated from 2 nasal swab (nos. 13, 14) and 
1 fecal swab (no. 19Dam) specimens collected on De-
cember 30; these were the specimens with high numbers 
of MERS-CoV copies (9.27 × 107 to 1.78 × 108 copies/
mL). The full-genome sequence of 1 virus culture isolate 
was obtained in parallel with that of the original virus in 
the original clinical specimen. We observed 3 nucleotide 
changes in ORF1b, spike, and membrane protein genes 
in the isolates after 2 passages in Vero E6 cells, of which 
2 were nonsynonymous, leading to changes in spike 
(S1251F) and membrane proteins (T8I). This finding 
highlights the importance of sequencing the viral genome 
directly from clinical specimens.
MERS-CoVs circulating in dromedaries on farm A 
during a 1-month period were genetically identical over the 
full 30,100-nt genome in 3 viruses and the spike protein of 
4 more viruses, giving a mutation rate of 0 nt substitutions 
per site per day (95% credible interval 0 to 2.7 × 10−6). The 
estimated mutation rate for epidemiologically unlinked hu-
man MERS-CoV was 3.1 × 10−6 (95% CI 2.4 × 10−6 to 3.8 
× 10−6) (9).
Conclusions
The unusual genetic stability of MERS-CoV in 
dromedaries, taken together with its high seroprevalence 
(7,10–13), raises the hypothesis that dromedaries might be 
the natural host for this virus. Further longitudinal stud-
ies of MERS-CoVs in dromedaries are needed to confirm 
this hypothesis.
Genome organization of the dromedary MERS-CoV 
detected in this study was identical to that of the virus in 
humans. The virus strains clustered phylogenetically with-
in clade B (9) and were most closely related to the strain 
MERS-CoV_FRA/UAE and to MERS-CoV detected in 
Buraidah (Saudi Arabia) and Al-Hasa (Figure). The farm 
is ≈300 km from United Arab Emirates and 600 km from 
Buraidah. Dromedaries move between Al-Hasa and Burai-
dah and, more limitedly, between Al-Hasa and United 
Arab Emirates.
The full-genome sequence of MERS-CoV from drom-
edaries in this study is 99.9% similar to genomes of hu-
man clade B MERS-CoV. The spike gene is the major 
determinant for virus host specificity. In comparison with 
other publically available human MERS-CoV sequences, 
we found 6-nt mutations in the spike gene unique to these 
dromedary viruses. Of these, 3 (S457G, L773F, and V810I) 
were nonsynonymous. These amino acid changes are lo-
cated outside the binding interface between MERS-CoV 
spike protein and human DPP4 receptor, suggesting these 
amino acid differences are unlikely to affect receptor bind-
ing. Thus, these dromedary viruses may retain capacity 
to infect humans, as Chu et al. suggested for dromedary 
MERS-CoV in Egypt (4).
MERS-CoV may be isolated from nasal swab speci-
mans and feces, indicating that both could be possible sourc-
es of virus transmission to humans and other animals, but 
virus detection rates were higher in nasal swab specimens. 
 
 
Table 1. RT-PCR	of	dromedary	camel	samples	for	MERS-CoV,	
Al-Hasa, Saudi Arabia* 
Farm,	sampling	date 
Age†/no. 
sampled 
No.	specimens	
positive/no.	tested 
Nasal Oral Fecal 
Farm	A     
 2013	Nov	30 Calf, 0 ND ND ND 
 Adult, 4 1/1 0/2 0/4 
 2013	Dec	4 Calf, 9 ND 0/9 0/7 
 Adult,	2 ND 0/2 0/2 
 2013	Dec	30 Calf,	8 7/8 0/1 0/6 
 Adult, 3 1/3‡ 0 1/3‡ 
 2014	Feb	14 Calf,	7 0/7 ND 0/7 
 Adult,	2 0/2 ND 0/2 
Farm	B:	2014	Feb	11 Calf, 3 0/3 ND 0/3 
 Adult, 3 0/3 ND 0/3 
*Data on individual dromedaries are provided	in	online	Technical	Appendix	
Table, http://wwwnc.cdc.gov/EID/article/20/7/14-0571-Techapp1.pdf. RT-
PCR,	reverse	transcription	PCR;	MERS-CoV,	Middle	East	respiratory	
syndrome	coronavirus;	ND,	not	done. 
†Adults are 6–14	y	of	age;	calves	are	40	d	to	2	y	of	age. 
‡Two different dromedaries were positive in nasal and fecal swabs. 
 
 
Table	2.Longitudinal	sampling	of	MERS-CoV–positive dromedary 
camel calves on farm A, Al-Hasa, Saudi Arabia* 
Calf no. 
Sample collection 
date Sex/age 
RT-PCR 
result Titer 
13 2013	Dec	30 F/1	y Positive <20 
 2014	Feb	14 F/1	y Negative 640 
15 2013	Dec	30 F/1	y Positive 20 
 2014	Feb	14 F/1	y Negative 160 
17 2013	Dec	30 F/40	d Positive 80 
 2014	Feb	14 F/3	mo Negative 1,280 
19 2013	Dec	30 F/1	y Positive NA 
 2014	Feb	14 F/1	y Negative 320 
*MERS-CoV,	Middle	East	respiratory	syndrome	coronavirus;	RT-PCR, 
reverse transcription PCR. 
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Our preliminary data suggest that preexisting MERS-CoV 
antibody might not completely protect against re-infection; 
however, this question needs more investigation.
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